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Abstract
Enterococci often acquire antimicrobial resistance through horizontal gene transfer. Relatedness between
enterococci with high level resistance to gentamicin and vancomycin isolated from humans, food and hospital
environment in Tandil County (Argentina) was investigated. PCR amplification for species determination was carried
out. Resistance to seven antimicrobials was studied; virulence genes (esp, cylA), vancomycin and gentamicin
resistance genes were investigated. In the isolates with high level antimicrobial resistance (gentamicin, vancomycin),
pulse-field gel electrophoresis was performed. Vancomycin-resistant E. faecium (n:13) were recovered from human,
food and hospital environment samples. All the isolates expressed high-level vancomycin and teicoplanin (vanA
genotype), as well high-level gentamicin and streptomycin resistance. Vancomycin-resistant E. faecium were
distributed among seven clonal types; esp gene was detected in clinical strains. There was no clonal relationship
with food vanA E. faecium, but these strains could pose a risk in intra/inter genus transfer of vanA determinant to
human-adapted strains. High-level gentamicin resistant E. faecalis (n:7) were recovered from human and food
samples. Glycopeptide resistance was not observed; cylA gene was detected in most of the clinical high-level
gentamicin resistant E. faecalis isolates. PFGE patterns showed four clonal types in high-level gentamicin resistant
E. faecalis strains; there was demonstrated clonal relatedness between isolates from different origin. In Argentina,
this is the first study showing a clonal relationship between high-level gentamicin resistant E. faecalis isolated from
food and humans. These results encourage the study of dissemination of clonal complexes with mobile resistance
genes.
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Introduction
Enterococci are intrinsically resistant to many antimicrobials
groups. Furthermore, these bacteria are capable of acquiring drug
resistance genes through horizontal gene transfer, such as high level
aminoglycosides and vancomycin resistance genes [1,2].
Enterococci colonize raw and fermented meat, as well as dairy
products, since they are part of the indigenous microbiota of mammal’s
gastrointestinal tract and are able to survive under adverse
environmental conditions [3,4].
Enterococcus faecalis and Enterococcus faecium have been
recognized as etiological agents of bacteremia, meningitis,
endocarditis, urinary tract and neonatal infections. Both species are
relevant pathogens for immunosuppressed patients or with prolonged
hospitalization [5-8].
Enterococci remain for long time-periods on environmental
surfaces, including medical equipment, bed rails and doorknobs. Also,
they are tolerant to heat, chlorine and some alcohol-based preparations
[9].
In enterococcal species, vancomycin resistance can be associated
with different van genotypes and Van phenotypes. VanA resistance is
mediated by transposon Tn1546 or closely related elements.
Expression of vanA gene leads to inducible high-level vancomycin
(Minimum Inhibitory Concentration, MIC, ≥ 64 µg/mL) and
teicoplanin (MIC ≥ 16 µg/mL) resistance, while vanB gene encodes for
variable levels of inducible vancomycin resistance. VanA is the most
frequent glycopeptide resistance type in clinical enterococci.
Nowadays, there is an increasing concern about vanA plasmid-
mediated transfer to methicillin-resistant Staphylococcus aureus
[10-12].
Over the last decades, detection of vanA genotype in E. faecium
from animals and from food of animal origin has been reported.
Initially, vancomycin resistance was linked with the use of avoparcin
(glycopeptide) as an animal growth promoter in the European Union,
EU [13-15]. After avoparcin was banned, glycopeptide-resistance
persisted, likely due to co-selection processes. However, at the same
time of avoparcin ban in the EU, vancomycin-resistant E. faecium were
not isolated from animal food products in the US [16,17]. In
Argentina, Delpech et al. [18] recovered vancomycin-resistant E.
faecium from artisanal salami, cow cheese and goat cheese.
The incidence of health-care associated infectious diseases produced
by vancomycin-resistant E. faecium in US hospitals has increased
significantly, becoming a nosocomial pathogen almost as prevalent as
E. faecalis [19].
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Frequently, hospitalized patients are treated with broad spectrum
antimicrobials. Therefore, presence of VanA or VanB vancomycin-
resistant enterococci in patients’ gastrointestinal tract and the risk of
invasive infections can be significantly increased. In humans, E.
faecium is the main reservoir of VanA and VanB type resistance. In
recent years, worldwide, colonization with vancomycin-resistant E.
faecium was considered endemic in many hospitals. Antimicrobial use
in patients seems to be a critical factor related to vancomycin-resistant
enterococci infections [20-22].
In South America, a multicenter study found that, ca. 22% of
enterococcal infections were caused by multi-resistant E. faecium,
similarly to what was reported in the US [23]. In Argentina, Corso et
al. [24], through a nation-wide antimicrobial resistance survey, proved
that most of vancomycin resistant enterococci carried vanA gene
(98%). In addition, these strains, expressed high-level resistance to
gentamicin (77.2%) and streptomycin (95.8%).
Many putative virulence factors from E. faecium have been
identified. One of the most relevant is a large surface protein (Esp)
covalently linked to the bacterial cell wall. Leavis et al. [25]
demonstrated that, in E. faecium, esp gene was encoded in a large
pathogenicity island and its presence was associated with nosocomial
outbreaks.
In enterococci, acquisition of high-level gentamicin resistance (MIC
≥ 2,000 μg/mL) is a significant therapeutic problem, particularly for
patients with severe infections. High-level aminoglycoside resistance
makes ineffective the synergistic effect between aminoglycosides and a
cell-wall-active agent, e.g. beta-lactams or vancomycin. aac(6′)-Ie-aph
(2")-Ia  gene, associated with high-level gentamicin resistance, is
widely spread in E. faecalis. This gene has been detected in strains from
human infections and among enterococci from food of animal origin
[26,27]. Bifunctional enzyme AAC6´-Ie-APH2´´-Ia confers resistance
to available aminoglycosides, except for streptomycin. aac(6’)-Ie-
aph(2”)-Ia gene is generally flanked by inverted repeats of IS256,
making up composite transposons, such as Tn5281 in E. faecalis. Fast
dissemination of the genetic determinant led to consider the impact of
its horizontal transferability among enterococcal species from different
origin. Hence, human enterococcal isolates are not the only ones to be
regarded as a reservoir of gentamicin resistance genes [28]. Among
high-level gentamicin resistant enterococci, chromosomal aph(2´´)-Ib,
aph(2´´)-Id and plasmidic aph(2´´)-Ic encode for gentamicin
modifying enzymes as well [29].
Recently, our group studied antimicrobial resistance profiles in
enterococci from minced meat, cow and goat cheese. In E. faecalis
recovered from these products, high-level gentamicin resistance was
detected [18].
Cytolysin is a chromosomal or plasmid encoded toxin with lytic
activity against eukaryotic cells, helping enterococci to escape from
host’s immune response [30]. In human infections and experimental
models, such as enterococcal endocarditis, cytolysin production has
shown to contribute with virulence [31]. Huycke et al. [32] reported
that ca. 60% of E. faecalis isolated from infection sites produced
cytolysin and it was associated with a five fold-increased risk of acutely
terminal outcome in patients with bacteremia. Moreover, high-level
gentamicin resistant (HLGR)-cytolysin producer E. faecalis influence
clinical and microbiological resolution of severe infectious diseases
[33].
In Argentina, genomic relationship between vancomycin-resistant
E. faecium and E. faecalis isolates with high-level gentamicin resistance
from human and food origin has not been studied so far.
The aim of this study was to investigate the relatedness between
HLGR E. faecalis and vancomycin-resistant E. faecium strains isolated
from humans, food and hospital environment in Tandil City,
Argentina.
Methods
Samples
Enterococci were recovered from the following sources: human,
hospital environment and food of animal origin. Isolates were collected
during the period January-December 2013, in Tandil County, at the
Southeast region of Buenos Aires Province, Argentina. All isolates were
stored, by triplicate, in brain heart infusion (BHI) broth with 30%
glycerol at -70°C.
Human source: Samples for microbiological diagnosis of invasive
infections caused by enterococci were collected from ICU´s (Intensive
Care Unit) patients at Hospital Ramon Santamarina de Tandil (HRS).
Samples: Blood, cerebrospinal, abdominal, pleural and synovial
puncture fluids. They were inoculated into BacT/ALERT culture
bottles (BacT/ALERT® 3D Microbial Detection System, BioMérieux,
Argentina). One significant isolate per patient, with an identifying
number, was included in the study.
Hospital environment: Samples from surveillance cultures, in order
to investigate the presence of vancomycin-resistant E. faecium in ICU-
HRS. Study of ICU´s environmental contamination was performed
investigating the surfaces close to patients (mattresses, bed rails and
doorknobs) and medical instruments in contact with them. This
procedure was carried out each time a vancomycin-resistant E. faecium
was isolated from a patient. Samples were spread on bile esculin agar
azide (BEEA) with 8 μg/mL of vancomycin and incubated for 48 h at
35°C. Each vancomycin-resistant E. faecium isolate from different
places was labelled with a numerical identification code.
In all patients, admitted and discharged from the UCI, rectal swabs
were done and processed as environmental samples.
Food: Artisanal meat and dairy products were purchased from 20
food retailers of Tandil County (ET1-ET20). In total, 146 samples (35
goat cheese, 32 cow cheese, 37 salami, 42 minced meat) were analyzed.
Samples were sent (refrigerated at 4°C) to the Microbiology Laboratory
and immediately processed.
Sampling and isolation techniques used have been previously
described by Delpech et al. [26]. Additionally, enrichment in BHI
broth with vancomycin (8 μg/mL) was performed for all samples. After
incubation for 24 h at 35°C, 10 μL of each enrichment culture were
spread on BEEA with vancomycin (8 μg/mL).
Susceptibility tests
MICs of all enterococcal isolates were determined by the agar
dilution method, according to Clinical and Laboratory Standards
Institute’s (CLSI) recommendations [34]. The following antimicrobials,
used in human medicine, were tested: ampicillin, ciprofloxacin,
linezolid, vancomycin, teicoplanin, gentamicin and streptomycin.
Quality control strains: E. faecalis ATCC 29212 (susceptible to
vancomycin and gentamicin), E. faecalis ATCC 51299 (resistant to
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gentamicin and vancomycin) and E. faecium ATCC 51559 (multidrug-
resistant).
Phenotypic characterization was performed by Gram staining,
catalase production, hydrolysis of pyrrolidonyl beta-naphthylamide,
and growth in BHI broth with 6.5% NaCl. Species-level
characterization was carried out by hydrolysis tests (arginine, pyruvate
and methyl-α-d-glucopyranoside), tolerance to tellurite 0.04%,
fermentation of carbohydrates (mannitol, arabinose, sorbitol, sucrose,
raffinose, and sorbose), motility in thioglycolate broth, and agar
pigment production [27].
Phenotypic confirmation was done using the Automated VITEK® 2
System (BioMérieux, Argentina).
Genomic DNA was extracted from phenotypically identified E.
faecalis and E. faecium isolates by a previously described boiling
method [35]. Molecular identification (polymerase chain reaction,
PCR) was performed.
For genus confirmation, the protocol described by Ke et al. [36] was
used. A tuf gene fragment (803 bp), encoding for a specific elongation
factor of the genus Enterococcus was amplified (Table 1). One
nanogram of genomic DNA was transferred directly to a 19 μL PCR
mixture containing 50 mM KCl, 10 mM Tris-HCl (pH: 9.0), 0.1%
Triton X-100, 2.5 mM MgCl2, 0.2 mM each Enterococcus-specific
primer, 200 mM each deoxynucleoside triphosphate, 3.3 mg/mL of
bovine serum albumin and 0.5 U of Taq polymerase. The PCR
mixtures were subjected to thermal cycling: 3 min at 96°C; then, 40
cycles of 1 s at 95°C (denaturation) and 30 s at 55°C (annealing-
extension step).
Gene (type) Nucleotide sequence (5′-3′) Annealing Temperature (°C)
tuf (Genus marker)
TACTGACAAACCATTCATGATG
55°C
AACTTCGTCACCAACGCGAAC
ddl(Species identfication)
ATCAAGTACAGTTAGTCT
54°C
ACGATTCAAAGCTAACTG
ddl(Species identification)
TAGAGACATTGAATATGCC
54°C
TCGAATGTGCTACAATC
cylA (Virulence factor)
ATGGATGGGACAGATGGAAA
54°C
AGCTGCGCTTAGTTCTGGAG
esp (Virulence factor)
GGAACGCCTTGGTATG
58°C
CCGCTTTTGGTGATTC
vanA (Glycopeptide resistance)
GTAGGCTGCGATATTCAAAGC
54°C
CGATTCAATTGCGTAGTCCAA
vanB (Glycopeptide resistance)
GGTATCAAGGAAACCTC
54°C
CTTCCGCCATCATAGCT
aac(6′)- Ie- aph(2″)-Ia (Aminoglycoside
resistance)
CAGGAATTTATCGAAAATGGTAGAAAAG
54°C
CACAATCGACTAAAGAGTACCAATC
aph (2´´)-Ib (Aminoglycoside resistance)
TATGGATTCATGGTTAACTTGGACGCTGAG
54°C
ATTAAGCTTCCTGCTAAAATATAAACATCTCTGCT
aph (2´´)-Ic (Aminoglycoside resistance)
GAAGTGATGGA AATCCCTTCGTG
54°C
GCTCTAACCCTTCAGAAATCCAGTC
aph (2´´)-Id (Aminoglycoside resistance)
GGTG GTTTTTACAGGAATGCCATC
54°C
CCCTCTTCATACCAATCCATATAACC
Table 1: Primers for identification of enterococci and antimicrobial resistance genes by PCR.
For species identification, PCR with species-specific primers:
ddlE.faecalis (941 bp) and ddlE.faecium (550 bp), for the chromosomally
encoded D-alanine: D-alanine (D-Ala:D-Ala) ligases was carried out.
A final volume of 100 μL containing 250 ng of DNA as template; 50
pmol of each oligodeoxynucleotide primer; 500 mM (each) dATP,
dCTP, dGTP and dTTP; 67 mM Tris-HCl (pH 8.8); 7 mM MgCl2; 17
mM ammonium sulfate; 10 mM b-mercaptoethanol; and 2 U of Taq
DNA polymerase. The cycles used were 94°C for 2 min for the first
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cycle; 94°C for 1 min, 54°C for 1 min, and 72°C for 1 min for the next
30 cycles; and 72°C for 10 min for the last cycle [37].
For detection of the cytolysin encoding gene cylA, PCR was
performed in a 25 μL total volume containing 20 pmol of each primer
(517 bp fragment), 200 mM of each dNTP, 1 U of Taq polymerase, 1.5
mm MgCl2, 2.5 mL of 10X PCR buffer and 2 μL of template DNA.
Reaction settings: 2 min at 94°C (initial denaturation) followed by 30
cycles of 30 s at 90°C (denaturation), 30 s at 54°C (annealing) and 1
min at 72°C (extension). A final extension cycle was performed at 72°C
for 8 min [27].
Enterococcal strains were screened for the esp gene by PCR,
according to the protocol of Coque et al. [38]. Primers were used for
amplifying an 800 bp gene fragment, encoding for esp: 5′-
GGAACGCCTTGGTATG-3′ and 5′-CCGCTTTTGGTGATTC-3′. The
reaction mixture consisted of 25 μL PCR master mix, 5 μL primers
(2μM), 15 μL sterile water and 5 μL of bacterial DNA. PCR was carried
out with the following thermal cycling profile: initial activation step at
95 °C for 15 min; 30 cycles of denaturation at 90°C for 30 seconds,
annealing at 58°C for 1 min, and extension at 72°C for 1 min; final
extension at 72°C for 10 min.
Resistance genes were detected by PCR using specific primers for
the aminoglycoside-modifying enzymes aac(6′)-Ie-aph(2″)-Ia (369 bp),
aph (2´´)-Ib (867 bp), aph (2´´)-Ic (444 bp) and aph (2´´)-Id (641 bp)
genes. Detection of high-level gentamicin resistance genes was done
according to Sparo et al. [27]. PCR was performed in a final volume of
25 μL, with 20 pmol of each primer, 1-2 colonies of each bacterial
isolate, 200 μM of each dNTP, 1 U of Taq polymerase, 1.5 μM MgCl2,
2.5 μL PCR 10X buffer and 2 μL of template DNA. Setting: a first cycle,
2 min at 94°C; followed by 30 cycles of 30 s at 90°C, 30 s at 54°C and 1
min at 72°C. A final extension cycle for 8 min at 72°C was done.
PCR for detection of vanA and vanB genes fragments (732 bp and
625 bp, respectively), which encode for D-Ala:D-Ala ligases of altered
substrate specifity, was carried out according to the same protocol of
Dutka-Malen et al. [37] for detection of ddl genes.
PFGE typing
Bacterial isolates were grown overnight in BHI broth. Chromosomal
DNA was prepared in agarose plugs, digested with the restriction
enzyme SmaI. DNA fragments were separated in a CHEF-DRIII
apparatus (Bio-Rad Laboratories, Richmond, CA, USA), following the
protocol of Corso et al. [24]. SmaI was chosen upon the base
composition (%G+C content) of the DNA of the microorganisms in
study. In the case of low GC bacteria, as E. faecalis and E. faecium,
SmaI (CCCGGG) is preferred, since it is advisable to use enzymes
which recognize relatively few sites on the genome and give a
resolvable and informative number of DNA fragments on the PFGE
gel. Lambda ladder (New England Biolabs, Beverly, MA, USA) was
used as molecular size standard. Similarity between isolates was
determined by visual comparison of isolates DNA banding pattern.
Interpretation of band patterns was carried out according to Tenover et
al. [39].
Isolates were defined as distinct strain types, or unrelated, if their
PFGE patterns differed by more than six bands. Types were named
using a capital letter following the alphabet order (e.g. type A, B, C, D).
Subtypes were defined as strains that differed by 2-6 bands, which were
considered closely or possibly related, and were named using an Arabic
number (e.g. subtype D1, D2) following the capital letter. Those
isolates whose restriction patterns had the same number and size of
bands were considered genetically indistinguishable and were assigned
to the same strain type.
Results
Vancomycin-resistant E. faecium were isolated from samples from
different sources: human, hospital environment and food of animal
origin. Food enterococci were recovered from samples collected at five
retailers (ET1, ET2, ET3, ET4, ET5).
Clinical vancomycin-resistant E. faecium were isolated from six
(n=6) patients with invasive infections, five from hemoculture and one
from abdominal puncture fluid (Figure 1). Also, vancomycin-resistant
E. faecium, were recovered from n=3 rectal swabs from patients
without enterococcal invasive diseases and n=1 in a mattress of a
patient (HRSER460) near other one with a positive rectal culture.
Figure 1: SmaI-PFGE patterns in vancomycin-resistant
Enterococcus faecium isolates (Lane 1: lambda ladder; Lane 2: E.
faecium EHRSER501 (human); Lane 3: E. faecium HRSER503
(human); Lane 4: HRSER509 (human); Lane 5: HRSER456
(human); Lane 6: HRSER457 (human); Lane 7: HRSER458
(human); Lane 8: HRSER459 (environment); Lane 9: HRSER460
(human); Lane 10: HRSER461 (human); Lane 11: CEBER95 (food);
Lane 12: CEBER180 (food); Lane 13: CEBER616 (food); Lane 14:
HRSER462 (human)).
Three vancomycin-resistant E. faecium were isolated from food:
handmade “salame”, cow cheese and sheep cheese from ET1, ET3 and
ET5, respectively. In all vancomycin-resistant E. faecium (n=13), vanA
gene was detected and MICs were as follow: vancomycin ≥ 256 μg/mL;
teicoplanin ≥ 256 μg/mL; linezolid ≤ 2.0 μg/mL; streptomycin>2,000
μg/mL. Moreover, human and hospital environment vancomycin-
resistant E. faecium were resistant to ampicillin (MIC ≥ 32 μg/mL),
ciprofloxacin ≥ 8.0 μg/mL and showed high-level resistance to
gentamicin (MIC>500 μg/mL). In contrast, vancomycin-resistant E.
faecium isolates from food were susceptible to ampicillin (MIC ≤ 2.0
μg/mL), ciprofloxacin (MIC 1.0-2.0 μg/mL) and without high-level
gentamicin resistance (MIC<500 μg/mL).
Vancomycin-resistant E. faecium isolates could be differentiated in
seven clonal types: VRE- A, VRE- B, VRE-C, VRE-D, VRE-E, VRE- F
and VRE-G. Clone A, were detected from two blood culture isolates,
from patients HRSER501 and HRSER503 with invasive infections and
other patient (HRSER509) with rectal colonization; all of them
hospitalized in ICU for the same period. Clone B included three
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isolates, a positive hemoculture from patient HRSER461 and an
environment contamination of a mattress following the discharge from
ICU of patient HRSER459 and a rectal colonization of a patient
(HRSER460) next to him; both without enterococcal invasive disease.
Clone C was represented by 2 clinical isolates from hemoculture and
an abdominal puncture fluid (patients HRSER456 and HRSER457),
admitted in ICU at different time. Clone D was identified in two
isolates of food, “salame” and sheep cheese, from different industrial
plants (ET1 and ET4), not produced in the same period. Those isolates
were identified as belonging to two subtypes (D1, D2) and considered
as closely related. Clonal types E (hemoculture), F (cow cheese) and G
(rectal swab) were represented by a single isolate each.
Only hospital vancomycin-resistant E. faecium isolates carried esp
gene, excluding clonal type VRE-G.
During 2013, from 10 patients were recovered E. faecalis producing
invasive infections and 4/10 of them showed high-level gentamicin
resistance. Regarding food of animal origin, E. faecalis was isolated
from different samples: minced meat for hamburgers, 5; regional
handmade “salame”, 2; sheep cheese, 4; cow cheese, 3. HLGR E. faecalis
(3/14) were recovered from minced meat for hamburgers elaborated in
ET4 (2/3) and “salame” (1/3), manufactured in ET1. Those isolates
were recovered in different seasons: summer (January) and fall (April).
All E. faecalis isolates expressing high-level gentamicin resistance
carried the aac(6′)- Ie- aph(2″)-Ia gene. None showed multiple
antimicrobial resistance. Determined MICs were: gentamicin >500
μg/mL; streptomycin ≤ 500 μg/mL; ampicillin ≤ 2.0 μg/mL; linezolid ≤
2.0 μg/mL; ciprofloxacin ≤ 0.5 - ≥ 8.0 μg/mL; vancomycin ≤ 1.0 μg/mL
and teicoplanin ≤ 0.5 μg/mL.
Most of the clinical HLGR E. faecalis carried cylA gene; were
recovered from blood (n=2) and abdominal puncture fluid (n=1). In
food enterococci, cylA was detected in minced meat isolates (n=2)
from ET4.
Figure 2: SmaI-PFGE patterns in high level gentamicin resistant
Enterococcus faecalis isolates (Lane 1: E. faecalis HRSRG16
(human); Lane 2: E. faecalis HRSRG215 (human); Lane 3: E. faecalis
HRSRG291 (human); Lane 4: E. faecalis HRSRG304 (human); Lane
5: E. faecalis CEBRG72 (food); Lane 6: E. faecalis CEBRG82 (food);
Lane 7: E. faecalis CEBRG87 (food); Lane 8: lambda ladder).
SmaI-PFGE (Figure 2) showed that seven HLGR E. faecalis isolates
were differentiated in four clonal types: EFA-A, EFA-B, EFA-C and
EFA-D. Clone A was represented by four isolates, two from UCI´s
patients HRSRG215 and HRSRG304 in the same period, isolated from
blood and abdominal puncture fluid, respectively, and two from food,
in minced meat from the same industrial plant (ET4) and period.
Clones B (hemoculture), C (hemoculture) and D (handmade “salame”)
included one isolate each. Moreover, cylA gene was detected in
pulsotypes EFA-A and EFA-B (Table 2).
Discussion
In the present study, vanA E. faecium was recovered from
handmade “salame” and cheese. Previously, Barbosa et al. [40] did not
detect vancomycin resistance in E. faecium isolated from traditional
fermented meat products. Recently, Ribeiro et al. [41] found vanA E.
faecium isolated from a traditional Portuguese dry fermented sausage.
Therefore, the presence of vanA E. faecium is variable according to
each analyzed geographic region.
Worldwide, VanA phenotype is linked to most of the human cases
of vancomycin resistant enterococci, and is mainly carried by E.
faecium. Spread of vancomycin-resistant E. faecium is a major global
issue due to its persistence in hospital environment, limited therapeutic
alternatives, and plasmidic vanA transfer [42].
Vancomycin-resistant E. faecium are the second most common
cause of nosocomial infections in the US [43]. In Europe, vancomycin-
resistant E. faecium prevalence is variable, ranging from less than 1%
in France and Sweden to higher than 20% in Greece, Ireland, Portugal
and the United Kingdom [44].
In Argentina, vancomycin-resistant E. faecium infections have been
reported since 1998. In different hospitals predominance of one
epidemic clone carrying vanA has been observed, with an increased
incidence of vancomycin-resistant E. faecium clonal spread [24]. In
2014, according to the Antimicrobial Resistance Surveillance Network
WHONET-Argentina (89 Microbiology Laboratories), clinical E.
faecium shows a high rate (61%) of vancomycin resistance
(www.antimicrobianos.com.ar).
In the current study, one pulso-type (VRE-B) was observed in two
patients and in the mattress of another one, suggesting strain
dissemination between patients and the environment. Kalocheretis et
al. [45] detected vancomycin-resistant E. faecium transmission
through a contaminated environment in different hospitals areas.
It should be noted that as a result of appearance of invasive
infections at ICU-HMRS, surveillance of vancomycin-resistant E.
faecium carriage in patients was started.
It is important to highlight that food vancomycin-resistant E.
faecium isolates were susceptible to ampicillin and ciprofloxacin, but
those of hospital origin were resistant to both antimicrobials.
Ampicillin and, frequently, fluoroquinolone resistance are phenotypic
markers for differentiating hospital and community vancomycin-
resistant E. faecium [46].
In this research, only hospital E. faecium strains carried esp gene,
also reported by Willems & Bontem [20]. According to Willems et al.
[47], emergence of E. faecium ST-17 lineage in hospital settings started
with adaptive changes, acquiring ampicillin resistance and a novel
putative pathogenicity island, linked to esp gene. In CC17 strains, esp
gene brings advantages in the adaptation to the hospital environment.
Furthermore, the strong linkage between ampicillin and ciprofloxacin
resistant E. faecium and CC17 has been widely accepted [48].
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Isolate Source Sample cylA/esp† HLGR/VR* SmaI-PFGE
E. faecium      
VREf-HRSER456 Clinical, ICU#†† Abdominal puncture fluid ** -/+ -/+ VREf-C
VREf-HRSER457 Clinical, ICU, ID Hemoculture -/+ -/+ VREf-C
VREf-HRSER458 Clinical, ICU, ID Hemoculture -/+ -/+ VREf-E
VREf-HRSER459 ICU. Environment Mattress -/+ -/+ VREf-B
VREf-HRSER460 Clinical, ICU, RC§ Rectal swab -/+ -/+ VREf-B
VREf-HRSER461 Clinical, ICU, ID Hemoculture -/+ -/+ VREf-B
VREf-HRSER462 Clinical, ICU, ID Rectal swab -/- -/+ VREf-G
VREf-HRSER501 Clinical, ICU, ID Hemoculture -/+ -/+ VREf-A
VREfHRSER503 Clinical, ICU. ID Hemoculture -/+ -/+ VREf-A
VREf-HRSER509 Clinical, RC Rectal swab -/+ -/+ VREf-A
VREf-CEBER95 Food, ET1§§ “salame” -/+ -/+ VREf-D1
VREf-CEBER180 Food, ET3 Sheep cheese -/+ -/+ VREf-D2
VREfCEBER616 Food, ET5 Cow cheese -/+ -/+ VREf-F
      
E. faecalis      
EFA-HRSRG16 Clinical, ICU, ID Hemoculture +/- +/- EFA-B
EFA-HRSRG215 Clinical, ICU, ID Hemoculture +/- +/- EFA-A
EFA-HRSRG291 Clinical, ICU, ID Hemoculture -/- +/- EFA-C
EFA-HRSRG304 Clinical, ICU, ID Abdominal puncture fluid (06/29/13) +/- +/- EFA-A
EFA-CEBRG72 Food, ET1 “salame” -/- +/- EFA-D
EFA-CEBRG82 Food, ET4 Minced meat +/- +/- EFA-A
EFA-CEBRG87 Food, ET4 Minced meat +/- +/- EFA-A
†: cylA gene, esp gene; *HLGR: aac(6′)- Ie- aph(2″)-Ia gene; VR: vanA gene; ‡VREf: vancmoycin-resistant E. faecium; #ICU (Intensive Care Unit); ††ID: Invasive
disease; ++: isolation date (mm/dd/yy); §RC: rectal colonization; §§ET: industrial plant; **EFA: high-level gentamicin resistant E. faecalis.
Table 2: Source and SmaI-PFGE of enterococcal isolates.
In this study, clonal complexes of vanA E. faecium were not
investigated. Nevertheless, the presence of esp gene, ampicillin and
ciprofloxacin resistance could suggest that clinical enterococcal isolates
might belong to clonal complex 17, since its spread in Argentina has
been reported (http://antimicrobianos.com.ar/2010/?cat=9).
The vanA gene is contained in Tn1546 or its derivatives, usually
located on transferable plasmids. Plasmids are readily found in
enterococci, and are common that clinical and commensal strains
harbor a number of such elements. They comprise an important
fraction of the auxiliary genome, and are responsible for much of the
horizontal gene transfer that has allowed antibiotic and virulence traits
to converge in hospital adapted lineages. Remarkably, different plasmid
types occur in E. faecium and E. faecalis, despite their close
phylogenetic relationship. The high content of plasmid and mobile
genetic elements in E. faecium human lineages seems to be relevant to
the emergence and persistence of their antibiotic resistance.
It is important to note that multiple drug resistance was not
observed in food enterococci. Besides, it was not detected a clonal
relationship between hospital-origin and food vancomycin-resistant E.
faecium. Hammerum [17] considered that E. faecium isolates of
animal origin are not themselves a hazard to humans, but they could
act as donors of antimicrobial resistance genes to other pathogenic
bacteria. The same variants of the vanA gene cluster, encoding for
vancomycin resistance, have been observed in human and animal
origin enterococci [49].
During 2013, in this study, in 10 patients with invasive infections,
HLGR E. faecalis (40%) were detected. In Argentina, in 2014,
according to WHONET Argentina, clinical HLGR E. faecalis (21.3%)
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were recovered (http://antimicrobianos.com.ar/2016/01/informe-
resistencia-2014-argentina/).
In this research, 3/14 (21.4%) food E. faecalis showed high-level
gentamicin resistance. In Germany, Peters et al. [50] reported a low
prevalence of HLGR enterococci isolated from food of animal origin.
In the current study, all characterized HLGR E. faecalis were not
multi-resistant and showed a high prevalence of cylA gene.
Additionally, aac(6′)- Ie- aph(2″)-Ia gene was detected in all the
isolates. Previously, in the same region, Sparo et al. [27] detected the
spread of HLGR E. faecalis and this aminoglycoside resistance
determinant in enterococci recovered from food, food producing
animals and humans.
In human HLGR E. faecalis, different clonal types were observed
(EFA-A, EFA-B, EFA-C). Previously, Murray et al. [51] found that
several E. faecalis isolates with high-level gentamicin resistance from
same and different locations presented distinct PFGE patterns. Few
studies have shown the existence of clonal relationship between clinical
isolates of E. faecalis. In this line, Larsen et al. [52] found HLGR E.
faecalis ST16 with similar PFGE types, isolated from pigs, pork, non-
hospitalized humans and patients with endocarditis. In the present
research, the clonal type EFA-A isolates were distributed among food
and human samples (minced meat, abdominal fluid and hemoculture).
Food isolates were recovered from the same establishment (ET4) and
processing period. These results showed the first evidence of clonal
spread between human and food HLGR E. faecalis in Argentina. In
Europe, Freitas et al. [53] observed the dissemination of a multidrug-
resistant E. faecalis clone in animals and humans. Presence of
transferable resistance mechanisms in food isolates constitutes a risk
for humans through the food chain. Sparo et al. [2] proved in vivo
horizontal transfer of high-level gentamicin resistance between
intestinal microbiota and food E. faecalis strains.
Therefore, presence of mobile genes such as vanA in E. faecium, and
aac(6′)- Ie- aph(2″)-Ia in E. faecalis implies the need of a continuous
sureveillance of these strains in hospitals and community settings [54].
Conclusion
In summary, in Argentina, there has not been so far evidence
regarding the clonal relationship between food and human
enterococcal strains. This is the first study that showed clonal
relationship between E. faecalis with high-level gentamicin resistance
isolated from food and humans. vanA E. faecium strains from hospital
origin belong to different clonal types than E. faecium from animal
food; although, it is important to emphasize that the number of isolates
tested is small. Food vanA E. faecium were not identified as a direct
cause of resistant enterococci in humans, but they could pose a risk for
the intra or inter genus transfer of vanA resistance determinant to
human-adapted strains.
Finally, this study demonstrated the spread of strains of vanA E.
faecium and HLGR E. faecalis of different origin in the ecosystem, with
potential for horizontal transfer resistance to other bacteria.
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